PharmaLeaders.com

News. Resources. Community.

  • Features
  • Channels
    • Biotech Channel
    • Clinical Channel
    • CME Channel
    • Compliance Channel
    • Device Channel
    • HIMSS Channel
    • Marketing Channel
    • Pharma Channel
    • R&D Channel
    • Telehealth Channel
    • Training Channel
  • Events
  • On Demand
  • White Papers
  • Vendors
    • Biotech Vendors
    • Clinical Vendors
    • CME Vendors
    • Compliance Vendors
    • Device Vendors
    • Marketing Vendors
    • Pharma Vendors
    • R&D Vendors
    • Training Vendors
  • Contributors

Register for Webinar – 10 Hot Technologies Impacting Life Sciences Marketing

07/23/2018 by Andrea

Brought to by PharmaLeaders & Presented by Collaborative Marketing Solutions Webinar: 10 Hot Technologies Impacting Life Sciences Marketing July 24 @ 1 pm Eastern [REGISTER NOW] Registration closed; this event has passed. Are you curious about ways that other organizations in the life sciences use the latest technologies to deliver dynamic and engaging programs? … [Read more...]

AXIM Biotech Moves Forward with Development of Medchew Rx Pharmaceutical Chewing Gum

05/02/2017 by Andrea

AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC: AXIM), a world leader in cannabinoid research and development, today announced that the company’s product development partner Quay Pharmaceuticals Ltd. (“Quay Pharm”) has obtained the relevant licenses from the British Home Office to import and work with the controlled drugs that are required to continue the development of AXIM … [Read more...]

Teewinot Life Sciences and Noramco sign letter of intent to produce cannabinoids with CannSynthesis™ biocatalysis technology

03/23/2017 by Andrea

Teewinot Life Sciences (Teewinot), the market leader in biocatalytic technologies for the production of pharmaceutical-grade cannabinoids, and Noramco, a global leading producer of controlled-substance active pharmaceutical ingredients (APIs), today signed a letter of intent to enter the commercial cannabinoids market using proprietary CannSynthesis™ technology. The agreement … [Read more...]

Questex Acquires ExL Events

07/11/2016 by Jennifer Hagemann

FOR IMMEDIATE RELEASE Questex Acquires ExL Events Acquisition of Leading Life Sciences Event Company Expands Company’s Services in Pharmaceutical, Life Science and Healthcare Markets NEWTON, Mass. (July 11, 2016) ─ Questex, a leading global business information and events company, today announced it has acquired ExL Events, Inc., expanding Questex's presence in the global … [Read more...]

Sudler & Hennessey Group Acquires Viscira

03/24/2016 by Jennifer Hagemann

Acquisition Adds Innovative New Media Communications and Technology Horsepower to the Company NEW YORK, March 24, 2016 /PRNewswire/ -- Sudler & Hennessey Group, a leading global healthcare communications network, is pleased to announce the acquisition of Viscira, a leader in digital marketing and cutting-edge media in the healthcare space. Viscira develops … [Read more...]

« Previous Page
  • Facebook
  • LinkedIn
  • Twitter

Choose Your Channel

Receive event announcements and special reports directly in your inbox.
  • This field is for validation purposes and should be left unchanged.

  • About Us
  • Sponsorship
  • Join Our Team
  • Contact Us

Copyright © 2023 PharmaLeaders.com. All rights reserved.